Investigating the role of pharmacogenomics in optimizing medication therapy for pregnant women: a pilot study

Each medication that is ordinarily used during pregnancy needs to go through an escalated pharmacokinetic examination. It is trying for a clinician to close whether a prescription's benefits offset its perils when it hasn't been evaluated. Basic thought should be given to getting taught consent, recording patient characteristics, recording drug piece and range, assessing plasma drug levels, and conveying the experience as a case report when clinicians decide to regulate medications that needy individual been completely focused on in pregnancy. Clinicians can augment treatment ampleness by preventing underdosing and limiting overabundance with the associated opposing effects by including improved dosing rules for pregnant patients. Most importantly, specialists could underwrite better medications for the best outcomes and success for both the mother and the undeveloped organism. The most often used intravenous enemy of contamination during pregnancy is cefazolin, which is cleared even more quickly due to extended renal excretion.[10] to stay aware of plasma obsessions above MIC during operation, a higher starting piece and more progressive association are required due to cefazolin's extended volume of movement during pregnancy and its accelerated opportunity.

Authors

Publication Details

Journal
Journal of Neonatal Surgery
Published
2025-02-04
DOI
https://doi.org/10.52783/jns.v14.1536
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigating the role of pharmacogenomics in optimizing medication therapy for pregnant women: a pilot study

Aayush Vaishnaw, Chandra Pratap Dhimar
Journal of Neonatal Surgery
Pharmaceutical studies and practices
article

Investigating the role of pharmacogenomics in optimizing medication therapy for pregnant women: a pilot study

Aayush Vaishnaw, Chandra Pratap Dhimar
article en

Abstract

Each medication that is ordinarily used during pregnancy needs to go through an escalated pharmacokinetic examination. It is trying for a clinician to close whether a prescription's benefits offset its perils when it hasn't been evaluated. Basic thought should be given to getting taught consent, recording patient characteristics, recording drug piece and range, assessing plasma drug levels, and conveying the experience as a case report when clinicians decide to regulate medications that needy individual been completely focused on in pregnancy. Clinicians can augment treatment ampleness by preventing underdosing and limiting overabundance with the associated opposing effects by including improved dosing rules for pregnant patients. Most importantly, specialists could underwrite better medications for the best outcomes and success for both the mother and the undeveloped organism. The most often used intravenous enemy of contamination during pregnancy is cefazolin, which is cleared even more quickly due to extended renal excretion.[10] to stay aware of plasma obsessions above MIC during operation, a higher starting piece and more progressive association are required due to cefazolin's extended volume of movement during pregnancy and its accelerated opportunity.

Journal of Neonatal SurgeryVol. 14(1S)
Openalex Percentile: Top 96%
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.